13,516 Shares in Amedisys, Inc. (NASDAQ:AMED) Acquired by Wealthquest Corp

Key Points

• Wealthquest Corp has acquired a new stake in Amedisys, Inc., purchasing 13,516 shares worth approximately $1.31 million, as reported in its latest SEC filing.
• Several hedge funds, including Norges Bank and Pentwater Capital Management, have significantly increased their stakes in Amedisys during the fourth quarter, indicating strong institutional interest.
• Amedisys reported earnings of $1.54 per share for the last quarter, exceeding analysts' expectations, with a revenue increase of 5.2% year-over-year amounting to $621.86 million.

Wealthquest Corp purchased a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,516 shares of the health services provider's stock, valued at approximately $1,310,000.

Several other institutional investors and hedge funds have also made changes to their positions in AMED. Alpine Associates Management Inc. increased its position in Amedisys by 11.7% in the first quarter. Alpine Associates Management Inc. now owns 992,120 shares of the health services provider's stock worth $91,900,000 after buying an additional 104,000 shares during the period. Federated Hermes Inc. increased its position in Amedisys by 8.7% in the first quarter. Federated Hermes Inc. now owns 3,101 shares of the health services provider's stock worth $287,000 after buying an additional 247 shares during the period. Meeder Advisory Services Inc. grew its stake in shares of Amedisys by 29.3% in the first quarter. Meeder Advisory Services Inc. now owns 3,039 shares of the health services provider's stock worth $282,000 after purchasing an additional 688 shares in the last quarter. LPL Financial LLC grew its stake in shares of Amedisys by 2.0% in the first quarter. LPL Financial LLC now owns 31,336 shares of the health services provider's stock worth $2,903,000 after purchasing an additional 605 shares in the last quarter. Finally, MRP Capital Investments LLC grew its stake in shares of Amedisys by 88.9% in the first quarter. MRP Capital Investments LLC now owns 595 shares of the health services provider's stock worth $55,000 after purchasing an additional 280 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Stock Down 0.1%

Shares of AMED traded down $0.07 during midday trading on Monday, reaching $98.44. 282,525 shares of the stock were exchanged, compared to its average volume of 366,394. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.24 billion, a price-to-earnings ratio of 38.32, a P/E/G ratio of 1.33 and a beta of 0.89. The firm has a 50 day simple moving average of $96.75 and a 200-day simple moving average of $94.20. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $99.00.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. The business had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. Amedisys had a return on equity of 12.91% and a net margin of 3.56%. The firm's revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 EPS. Research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Ratings Changes

AMED has been the subject of several recent analyst reports. Wall Street Zen cut Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Royal Bank Of Canada reissued an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.